marketinsider

Get Ready to Geek Out: Reviva Pharmaceuticals Shares Exciting Clinical Data on Brilaroxazine at ASPET 2023 Annual Meeting!

marketinsider04 mins

Reviva Pharmaceuticals Announces Presentation at Scientific Conference Exciting news from Reviva Pharmaceuticals as they recently announced a presentation at a scientific conference highlighting the latest data on brilaroxazine. The data reinforces brilaroxazine’s differentiated clinical pharmacology and safety profile, setting it apart from other drugs on the market. Unique Co-administration Potential One of the standout findings…

Read More

Breaking News: Binance Australia Extends AUD Withdrawal Deadline to June 1st – Don’t Miss Out!

marketinsider03 mins

Embracing Change: Binance Australia’s Local Payments Update The Current Situation Binance Australia has recently provided an update regarding its local payments, specifically in relation to AUD withdrawals via bank transfers. The cryptocurrency exchange has announced that AUD withdrawals will be allowed until 1 June at 5 pm (AEST). This decision has left many users scrambling…

Read More

Cannes Film Festival Buzz: Auschwitz Stands Out as a Clever and Unconventional Favorite

marketinsider03 mins

A Powerful Auschwitz-Set Psychological Horror Film Takes Cannes by Storm The Zone of Interest: A Bone-Chilling Holocaust Drama Clever, Personable, and Wonderfully Unconventional A powerful Auschwitz-set psychological horror film, “The Zone of Interest”, was emerging as the hot ticket of the first week at Cannes, with reviews on Saturday near-unanimous in praise. A “bone-chilling Holocaust…

Read More

Unleashing the Excitement: Cannes Awaits the Epic Collaboration of DiCaprio and Scorsese

marketinsider05 mins

Cannes Premiere: “Killers of the Flower Moon” Hollywood Comes to the French Riviera Cannes is set for another major Hollywood premiere on Saturday, as Leonardo DiCaprio and Martin Scorsese bring their Native American crime epic, “Killers of the Flower Moon”, to the French Riviera. Lips are tightly sealed around the three-and-a-half hour movie, but it…

Read More

Breaking News: Intercept’s FDA Advisory Committee Meeting for Obeticholic Acid Yields Promising Results in Treating Pre-Cirrhotic Fibrosis Due to NASH

marketinsider04 mins

Intercept Announces Outcome of FDA Advisory Committee Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH Yesterday, the FDA Advisory Committee met to discuss the benefits and risks of using OCA 25 mg as a treatment for NASH patients with stage 2 or 3 fibrosis. The outcome of the meeting was…

Read More